CENTRIC HEALTH (CHH) Earns Buy Rating from Beacon Securities

Beacon Securities reissued their buy rating on shares of CENTRIC HEALTH (TSE:CHH) in a research report released on Friday morning, Zacks.com reports.

TSE:CHH opened at C$0.29 on Friday. CENTRIC HEALTH has a 1 year low of C$0.20 and a 1 year high of C$0.51. The company has a market capitalization of $61.38 million and a PE ratio of -1.88.


Centric Health Corporation provides healthcare services to patients and customers in Canada. It operates through two segments, Specialty Pharmacy, and Surgical and Medical Centres. The Specialty Pharmacy segment provides traditional pharmacy services, such as compounding and dispensing medications, as well as clinical and specialty services for long term care and retirement communities.

Further Reading: Index Funds

Receive News & Ratings for CENTRIC HEALTH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CENTRIC HEALTH and related companies with MarketBeat.com's FREE daily email newsletter.